SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015868
Filing Date
2021-11-15
Accepted
2021-11-15 07:31:05
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20210930x10q.htm   iXBRL 10-Q 1164737
2 EX-31.1 zyne-20210930xex31d1.htm EX-31.1 11551
3 EX-31.2 zyne-20210930xex31d2.htm EX-31.2 11288
4 EX-32.1 zyne-20210930xex32d1.htm EX-32.1 6095
5 EX-32.2 zyne-20210930xex32d2.htm EX-32.2 6116
  Complete submission text file 0001558370-21-015868.txt   5201922

Data Files

Seq Description Document Type Size
6 EX-101.SCH zyne-20210930.xsd EX-101.SCH 36105
7 EX-101.CAL zyne-20210930_cal.xml EX-101.CAL 44145
8 EX-101.DEF zyne-20210930_def.xml EX-101.DEF 127121
9 EX-101.LAB zyne-20210930_lab.xml EX-101.LAB 314575
10 EX-101.PRE zyne-20210930_pre.xml EX-101.PRE 260606
11 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20210930x10q_htm.xml XML 1010369
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 211406340
SIC: 2834 Pharmaceutical Preparations